Kohlberg to Acquire Majority Stake in Worldwide Clinical Trials

Kohlberg to Acquire Majority Stake in Worldwide Clinical Trials

An affiliate of Kohlberg & Company, LLC has entered into a definitive agreement to acquire a majority stake in Worldwide Clinical Trials (WCT), in partnership with WCT’s management team. Following the sale to Kohlberg, WCT’s former owner, The Jordan Company, will retain a meaningful minority equity stake in the company. WCT is a full-service contract research organization (CRO) focused on CNS, cardiovascular, metabolic, immune-mediated inflammatory disorders, oncology and rare diseases. Its global footprint spans nearly 60 countries with more than 3,200 team members. Kohlberg & Company LLC is a private equity firm specializing in add-on acquisitions, follow-on acquisitions,... Read More »
BioScrip and Option Care Merge

BioScrip and Option Care Merge

BioScrip (NASDAQ: BIOS) and Option Care announced they are merging in perhaps the biggest home health deal of 2019 so far. Option Care provides home and alternate treatment site infusion services and is owned by Madison Dearborn Partners, LLC (MDP) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA). BioScrip offers infusion and home care management solutions, and as one of the largest nationwide providers, it services nearly 70 service locations nationwide. It partners with physicians, hospital systems,  and skilled nursing facilities to provide patients access to post-acute care services. BioScrip has made a few significant acquisitions itself over the past few years worth noting. It... Read More »